Storia in 2 fonti

Novo Nordisk launches higher-dose Wegovy for those seeking greater weightloss

A new and higher dose of obesity drug Wegovy has joined Novo Nordisk’s semaglutide portfolio, giving patients and doctors more options for treatment.

Raccontata da

thehindubusinessline.com

koreatimes.co.kr

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

thehindubusinessline.comStai leggendo1 mesi fa

Novo Nordisk launches higher-dose Wegovy for those seeking greater weightloss

A new and higher dose of obesity drug Wegovy has joined Novo Nordisk’s semaglutide portfolio, giving patients and doctors more options for treatment.

originale

koreatimes.co.kr1 mesi fa

EU regulator approves pill form of Novo Nordisk's Wegovy weight loss drug - The Korea Times

COPENHAGEN — Novo Nordisk has obtained approval for the pill form of its popular Wegovy anti-obesity drug in the European Union, the bloc's medicin...

Leggi questa versione → originale

Timeline cronologica

giovedì 21 maggio 2026·thehindubusinessline.com
Novo Nordisk launches higher-dose Wegovy for those seeking greater weightloss
A new and higher dose of obesity drug Wegovy has joined Novo Nordisk’s semaglutide portfolio, giving patients and doctors more options for treatment.
venerdì 22 maggio 2026·koreatimes.co.kr
EU regulator approves pill form of Novo Nordisk's Wegovy weight loss drug - The Korea Times
COPENHAGEN — Novo Nordisk has obtained approval for the pill form of its popular Wegovy anti-obesity drug in the European Union, the bloc's medicin...